RecruitingNCT06026345
Affera Global Registry
The Affera Global Registry is a Prospective, Global, Multi-center, Observational Post-market Registry (PMR)
Sponsor
Medtronic Cardiac Ablation Solutions
Enrollment
540 participants
Start Date
Dec 22, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The Affera Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to describe clinical performance and safety data in a broad patient population treated with the Affera Platform.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Subject is ≥ 18 years of age or minimum age as required by local regulations
- Planned procedure using the commercially available Affera Platform
- Willing and able to comply with study requirements and give IC (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements
Exclusion Criteria1
- Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager
Interventions
DEVICEAffera Platform
A cardiac ablation will be performed using the Affera Platform
Locations(12)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06026345
Related Trials
The CONFORM Pivotal Trial
NCT0514779283 locations
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT0680821732 locations
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT072275327 locations
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT0645509846 locations
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698127 locations